Role of Fas/FasL Interaction in Physiology and Pathology: The Good and the Bad
Open Access
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 87 (1) , 1-7
- https://doi.org/10.1006/clin.1997.4504
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.Journal of Clinical Investigation, 1996
- Genetically Programmed Development of Salivary Gland Abnormalities in the NOD (Nonobese Diabetic)-scidMouse in the Absence of Detectable Lymphocytic Infiltration: A Potential Trigger for Sialoadenitis of NOD MiceClinical Immunology and Immunopathology, 1996
- Placental Expression of HLA Class I GenesAmerican Journal of Reproductive Immunology, 1996
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Retroviruses, apoptosis and autogenesImmunology Today, 1993
- Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative DiseaseAnnual Review of Immunology, 1991
- Hypothesis. Auto-antibodies and immunological theories: An analytical reviewClinical Immunology and Immunopathology, 1975